ISMRM25 - DCE for Oncology

ISMRM & ISMRT Annual Meeting & Exhibition • 10-15 May 2025 • Honolulu, Hawai'i

DCE for Oncology

Weekend Course

ORGANIZERS: Houchun Hu, Mami Iima, Sonal Krishan, Yoshiharu Ohno, Janio Szklaruk, Takeshi Yokoo

Saturday, 10 May 2025

316B

13:00 - 17:00

Moderators: Eun Sook Ko & Sudhir Pathak

Skill Level: Basic to Advanced

Session Number: WE-09

CME Credit

Session Number: WE-09

Overview
This session will delve into dynamic contrast-enhanced (DCE) MRI applications in oncology, focusing on breast, prostate, ovarian, rectal, liver, lung/mediastinum, and head and neck cancers.

Target Audience
Radiologists, oncologists, and researchers interested in advanced imaging techniques and their clinical applications in oncology.

Educational Objectives
As a result of attending this course, participants should be able to:
• Describe the principles and clinical utility of DCE MRI in various oncological contexts;
• Interpret DCE MRI findings for differential diagnosis and treatment planning; and
• Discuss the latest advancements and research trends in DCE MRI applications across multiple cancer types.

13:00		Breast View Presentation Video Ritse Mann Impact: DCE is the key technique for any breast MRI protocol (Ultra)fast sequences during inflow of contrast improve the value of breast MRI Non-parametric assessment appears most robust for modelling The use of AI may reduce, but not obviate the need for DCE
13:30		The Role of Dynamic Contrast-Enhanced MRI in Gynecologic Tumors × Video Permission Withheld Tsukasa Saida Impact: DCE-MRI in O-RADS MRI improves diagnostic accuracy in differentiating benign from malignant ovarian tumors. This lecture covers practical applications, common pitfalls, and advanced DCE techniques, including quantitative analysis, with a brief mention of uterine cancer evaluation.
14:00		Educational program: Role of DCE-MRI of the Prostate in Oncology × Video Permission Withheld Tsutomu Tamada, Yu Ueda Impact: This lecture will outline the evolution of dynamic contrast-enhanced MRI (DCE-MRI) in prostate MRI, the imaging methods, the role of tumor detection and extraprostatic extension, and the possibility of omitting DCE-MRI.
14:30		Gadoxetic Acid-Enhanced Magnetic Resonance Imaging for Diagnosing Hepatocellular Carcinoma × Video Permission Withheld Azusa Kitao Impact: This presentation reveals several points for better scanning and interpretation of the dynamic and hepatobiliary phases of gadoxetic acid-enhanced magnetic resonance imaging in hepatocellular carcinoma diagnosis.
15:00		Break & Meet the Teachers
15:30		Lung/Mediastinum View Presentation Video Yoshiyuki Ozawa Impact: DCE-MRI is highly useful for diagnosing lung tumors, distinguishing malignancy, classifying lung cancer subtypes, and monitoring treatment. It also helps differentiate thymoma from other mediastinal tumors, including thymic carcinoma and lymphoma.
16:00		DCE for Oncology: Head & Neck View Presentation Video Noriyuki Fujima Impact: DCE is an imaging technique assessing tissue perfusion and permeability. Though not routine in head and neck imaging, it aids in cancer prognosis and tumor differentiation. This lecture covers its current state and clinical significance.
16:30		DCE Post- Processing (Breast & Prostate) View Presentation Video KyungHyun Sung Impact: This presentation will cover DCE-MRI data acquisition, and quantitative and semi-quantitative modeling approaches in breast and prostate cancers. Challenges and emerging AI-driven approaches in DCE-MRI analysis will be discussed.